Morbach, Caroline http://orcid.org/0000-0002-0920-6094
Moser, Nicola
Cejka, Vladimir
Stach, Michael
Sahiti, Floran
Kerwagen, Fabian
Frantz, Stefan
Pryss, Rüdiger
Gelbrich, Götz
Heuschmann, Peter U.
Störk, Stefan
,
Maack, C.
Ertl, G.
Fassnacht, M.
Wanner, C.
Leyh, R.
Volkmann, J.
Deckert, J.
Faller, H.
Jahns, R.
Funding for this research was provided by:
Bundesministerium für Bildung und Forschung (BMBF 01EO1004, BMBF 01EO1504)
Universitätsklinikum Würzburg
Article History
Received: 12 July 2023
Accepted: 31 December 2023
First Online: 18 January 2024
Declarations
:
: C.M. reports research cooperation with the University of Würzburg and Tomtec Imaging Systems funded by a research grant from the Bavarian Ministry of Economic Affairs, Regional Development and Energy, Germany; she is supported by the German Research Foundation (DFG) within the Comprehensive Research Center 1525 “Cardio-immune interfaces” (453989101, project C5) and receives financial support from the Interdisciplinary Center for Clinical Research—IZKF Würzburg (advanced clinician-scientist program; AdvCSP 3). She further received advisory and speakers honoraria as well as travel grants from Tomtec, Alnylam, AKCEA, Pfizer, Boehringer Ingelheim, SOBI, AstraZeneca, NovoNordisk, Alexion, Janssen, and EBR Systems; principal investigator in trials sponsored by Alnylam, Bayer, NovoNordisk, and AstraZeneca.N.M. has no conflicts of interest regarding the present work.V.C. has no conflicts of interest regarding the present work.M.S. has no conflicts of interest regarding the present work.F.S. has no conflicts of interest regarding the present work.F.K. has no conflicts of interest regarding the present work.S.F. has no conflicts of interest regarding the present work.R.P. has no conflicts of interest regarding the present work.G.G. reports research cooperation with the University Hospital Würzburg and Tomtec Imaging Systems funded by a research grant from the Bavarian Ministry of Economic Affairs, Regional Development and Energy, Germany.PU. H. has no conflicts of interest regarding the present work.S.S. is supported by the CHFC Würzburg, and by the German Federal Ministry of Education and Research (BMBF). He has received consultancy and lecture fees from AstraZeneca, Bayer, Boehringer Ingelheim, Novartis, Pfizer, and Servier.